NLRP3 and colitis: The colitis group showed a significant increase in both colon mTOR content and NLRP3 gene expression, with 3.61‐fold (F = 528.4, p < 0.0001) and 3.68‐fold (F = 66.14, p < 0.0001) increases, respectively, compared to the normal control group.